ProQR Therapeutics N.V. buy Chardan Capital
Start price
10.05.24
/
50%
€1.86
Target price
10.05.25
€2.32
Performance (%)
-6.56%
Price
24.05.24
€1.74
Summary
This prediction is currently active. With a performance of -6.56%, the BUY prediction for ProQR Therapeutics N.V. by Chardan_Capital is down slightly. This prediction currently runs until 10.05.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| ProQR Therapeutics N.V. | -0.114% |
| iShares Core DAX® | -0.654% |
| iShares Nasdaq 100 | 0.903% |
| iShares Nikkei 225® | -0.740% |
| iShares S&P 500 | -0.013% |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.27
08.11.23
08.11.23
€1.87
08.11.24
08.11.24
37.28%
24.05.24
24.05.24
